Article

Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of…

medRxiv · 2021 · Jongeneelen, M.; Kaszas, K.; Veldman, D.; Huizingh, J.; van der Vlugt, R.; Schouten, T.; Zuijdgeest, D.; Uil, T.; van Roey, G.; Guimera, N.; Navis, M.; Bos, R.; Le Gars, M.; Sadoff, J.; Muchene, L.; Juraszek, J.; Langedijk, J. P.; Vogels, R.; Custers, J.; Schuitemaker, H.; Brandenburg, B.

Key facts

Title Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern
First author Jongeneelen, M.; Kaszas, K.; Veldman, D.; Huizingh, J.; van der Vlugt, R.; Schouten, T.; Zuijdgeest, D.; Uil, T.; van Roey, G.; Guimera, N.; Navis, M.; Bos, R.; Le Gars, M.; Sadoff, J.; Muchene, L.; Juraszek, J.; Langedijk, J. P.; Vogels, R.; Custers, J.; Schuitemaker, H.; Brandenburg, B.
Journal medRxiv
Published Jul 9, 2021
DOI 10.1101/2021.07.01.450707
Devices mentioned K822496
Product codes mentioned JIT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature